October 11-12, 2017: Meeting Materials FDA Generated
Final Agenda: Oct. 11-12, 2017 FDA Discussion Questions: Oct. 11-12, 2017 Roster: Oct. 11-12, 2017 Roundtable Scenarios and Questions: Oct. 11-12, 2017 Webcast Information: Oct. 11-12, 2017 FDA Executive Summary : Oct. 11-12, 2017 Bibliography: Oct. 11-12, 2017 Clinical Trials and Medical Device, FDA, Owen Faris, Ph.D. Partnering with Patients, FDA, Kathryn O'Callaghan PEAC Meeting, Day 1 Summary, FDA, Dr. Michelle Tarver PEAC 24hr Summary Clinical Trail Glossary Terms Transcript: Oct. 11, 2017 Transcript: Oct. 12, 2017 October 11-12, 2017: Meeting Materials Non-FDA Generated
Industry Practices that Benefit/Will Benefit by Patient Engagement, Tufts, Ken Getz Patient Engagement Efforts with the Clinical Trial Enterprise , Bray Patrick-Lake, Duke Patient Involvement in the Design of Clinical Trials, AstraZeneca, Faye O'Brien, Advocate Engagement and Clinical Trials, NCI SCRIPPS, VitalCrowd, Anna McCollister-Slipp Patient Centered Designs Case Study, Johnson Patient Recruitment, Enrollment, and Retention, Boston Scientific, Dr. Kenneth Stein Patient and Public Driven Research, PCORI, Kristin Carman Patient Recruitment, Enrollment, and Retention, NORD, Paul Melmeyer Considerations in Reporting Results of Clinical Trials,NLOM, Dr. Deborah Zarin The mPower Study,Sage BIONETWORKS, John Wilbanks
Content current as of:
11/08/2017
Back to Top
